Journal of Cataract & Refractive Surgery
Volume 31, Issue 9 , Pages 1773-1776 , September 2005

In-use study of potential bacterial contamination of ophthalmic moxifloxacin

,Accepted 16 February 2005.

References 

  1. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002;133:463–466
  2. Ritterband DC, Shah M, Seedor J. Antibiotic prophylaxis in clear corneal cataract surgery. [letter] Arch Ophthalmol. 2003;121:296
  3. Kowalski RP, Dhaliwal DK, Karenchak LM, et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol. 2003;136:500–505
  4. Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol. 2002;86:418–423
  5. Pisella P-J, Fillacier K, Elena P-P, et al. Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic Res. 2000;32:3–8
  6. De Saint Jean M, Debbasch C, Brignole F, et al. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr Eye Res. 2000;20:85–94
  7. de Jong C, Stolwijk T, Kuppens E, et al. Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma. Graefes Arch Clin Exp Ophthalmol. 1994;232:221–224
  8. Baudouin C, de Lunardo C. Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol. 1998;82:39–42
  9. Schein OD, Wasson PJ, Boruchoff SA, Kenyon KR. Microbial keratitis associated with contaminated ocular medications. Am J Ophthalmol. 1988;105:361–365
  10. Pereira IC, Alfonso E, de Souza MACM, et al. Avaliação de contaminaçao˜ de produtos oftálmicos em uso. Arq Bras Ophthalmol. 1992;55:15–18
  11. Geyer O, Bottone EJ, Podos SM, et al. Microbial contamination of medications used to treat glaucoma. Br J Ophthalmol. 1995;79:376–379
  12. Schein OD, Hibberd PL, Starck T, et al. Microbial contamination of in-use ocular medications. Arch Ophthalmol. 1992;110:82–85
  13. Høvding G, Sjursen H. Bacterial contamination of drops and dropper tips of in-use multidose eye drop bottles. Acta Ophthalmol (Copenh). 1982;60:213–222
  14. Stevens JD, Matheson MM. Survey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eye drop dispensing. Br J Ophthalmol. 1992;76:36–38

 Presented in part at the ASCRS Symposium on Cataract, IOL and Refractive Surgery, San Diego, California, USA, May 2004.Supported in part by Research to Prevent Blindness, New York, New York, USA.No author has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(05)00429-3

doi: 10.1016/j.jcrs.2005.02.043

Journal of Cataract & Refractive Surgery
Volume 31, Issue 9 , Pages 1773-1776 , September 2005

Article Tools

* Image Usage & Resolution